Potential Roles of Fibronectin in Cutaneous Wound Repair

Archives of Dermatology

Volumn 124, Issue 2, 1988, Pages 201-206

  Clark, Richard A F ^a  

^a Universtiy of Pennsylvania   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; GROWTH FACTOR; OPSONIN;

CHEMOTAXIS; DRUG THERAPY; EDITORIAL; HUMAN; TOPICAL DRUG ADMINISTRATION; WOUND HEALING;

ACUTE-PHASE REACTION; CELL DIVISION; CELL MOVEMENT; CHEMOTAXIS, LEUKOCYTE; FIBROBLASTS; FIBRONECTINS; HUMAN; PHAGOCYTOSIS; WOUND HEALING; WOUNDS AND INJURIES;

EID: 0023851909     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1988.01670020019010     Document Type: Article

References (91)

1. Martin DE, Reese MC, Maher JE, et al: Tissue debris at the injury site is coated by plasma fibronectin and subsequently removed by tissue macrophages. Arch Dermatol 1988;124:226–229.
2. Cheng CY, Martin DE, Leggett CG, et al: Fibronectin enhances healing of excised wounds in rats. Arch Dermatol 1988;124:221–225.
3. Hynes R: Molecular biology of fibronectin. Annu Rev Cell Biol 1985;1:67–90.
4. Hayashi M, Yamada KM: Domain structure of the carboxylterminal half of human plasma fibronectin. J Biol Chem 1983; 258:3332–3340.
5. Sekiguchi K, Hakomori SI: Domain structure of plasma fibronectin. J Biol Chem 1983;258:3967–3973.
6. Ruoslahti E, Pierschbacher MD: Arg-Gly-Asp: A versatile cell recognition signal. Cell 1986;44:517–518.
7. Owens JO, Baralle FE: Mapping the collagen-binding site of human fibronectin by expression in Escherichia coli. EMBO J 1986;5:2825–2830.
8. Hynes R: Integrins: A family of cell receptors. Cell 197;48:549–554.
9. Ginsberg MH, Loftus J, Ryckwaert J, et al: Immunochemical and aminoterminal sequence comparison of two cytoadhesins indicates they contain similar or identical β-subunits and distinct α-subunits. J Biol Chem 1987;262:5437–5440.
10. Norris DA, Clark RAF, Swigart LM, et al: Fibronectin fragment(s) are chemotactic for human peripheral blood monocytes. J Immunol 1982;129:1612–1618.
11. Clark RAF, Wikner NE, Norris DA, et al: Cryptic chemotactic activity for human monocytes resides in the cell-binding domain of fibronectin. J Cell Biol 1985;101:217a.
12. Postlethwaite AE, Kang AH: Collagen and collagen peptideinduced chemotaxis of human blood monocytes. J Exp Med 1976;143:1299–1307.
13. Senoir RM, Griffin GL, Mecham RP: Chemotactic activity of elastin-derived peptides. J Clin Invest 1980;66:859–862.
14. Ali U, Hynes RO: Effect of LETS glycoprotein on cell motility. Cell 1978;14:439–446.
15. Postlethwaite AE, Keski-Oja J, Balian G, et al: Induction of fibroblast chemotaxis by fibronectin: Localization of the chemotactic region to a 140 000 molecular weight non-gelatin-binding fragment. J Exp Med 1981;15:494–499.
16. Seppa HEJ, Yamada KM, Seppa ST, et al: The cell binding fragment of fibronectin is chemotactic for fibroblasts. Cell Biol Int Rep 1981;5:813–819.
17. Bowersox JC, Sorgente N: Chemotaxis of aortic endothelial cells in response to fibronectin. Cancer Res 1982;42:2547–2551.
18. Mosesson MW, Umfleet RA: The cold-insoluble globulin of human plasma: I. Purification, primary characterization, and relationship to fibrinogen and other cold-insoluble fraction components. J Biol Chem 1970;245:5728–5736.
19. Ginsberg MH, Painter RG, Birdwell C, et al: The detection, immunofluorescent localization, and thrombin induced release of human platelet-associated fibronectin antigen. J Supramol Struct 1979;11:167–173.
20. Kaplan JE, Molnar J, Saba TM, et al: Comparative disappearance and localization of isotopically labelled opsonic protein and soluble albumin following surgical trauma. J Reticuloendothel Soc 1976;20:375–384.
21. Grinnell F, Billingham RE, Burgess L: Distribution of fibronectin during wound healing in vivo. J Invest Dermatol 1981;76:181–189.
22. Robbins AB, Doran JE, Reese AC, et al: Cold-insoluble globulin levels in operative trauma: Serum depletion, wound sequestration, and biological activity: An experimental and clinical study. Ann Surg 1980;46:663–672.
23. Clark RAF, Dvorak HF, Colvin RB: Fibronectin in delayedtype hypersensitivity skin reactions: Associations with vessel permeability and endothelial cell activation. J Immunol 1981; 126:787–793.
24. Clark RAF, Horsburgh RA, Hoffman A, et al: Fibronectin deposition in delayed-type hypersensitivity reactions of normals and a patient with afibrinogenemia. J Clin Invest 1984;74:1011–1016.
25. Petersen TE, Thøgersen HC, Skorsjengaard K, et al: Partial primary structure of bovine plasma fibronectin: Three types of internal homology. Proc Natl Acad Sci USA 1983;80:137–141.
26. DePetro G, Barlati S, Vartio T, et al: Transformationenhancing activity of gelatin-binding fragments of fibronectin. Proc Natl Acad Sci USA 1981;78:4965–4969.
27. McDonald JA, Kelley DG: Degradation of fibronectin by human leukocyte elastase: Release of biologically active fragments. J Biol Chem 1980;255:8848–8858.
28. Rourke FJ, Blumenstock FA, Kaplan JE: Effect of fibronectin fragments on macrophage phagocytosis of gelatinized particles. J Immunol 1984;132:1931–1936.
29. Gudewicz PW, Molnar J, Lai MZ, et al: Fibronectinmediated uptake of gelatin-coated latex particles by peritoneal macrophages. J Cell Biol 1980;87:427–433.
30. Van de Water L, Schoeder S, Crenshaw EB, et al: Phagocytosis of gelatin-latex particles by a murine macrophage line is dependent on fibronectin and heparin. J Cell Biol 1981;90:32–39.
31. Doran JE, Mansberger AR, Edmondson HT, et al: Cold insoluble globin and heparin interactions in phagocytosis by macrophage monolayers: Lack of heparin requirement. J Reticuloendothel Soc 1981;29:275–283.
32. Grinnell F, Bennett MH: Fibroblast adhesion on collagen substrata in the presence and absence of plasma fibronectin. J Cell Sci 1981;48:19–34.
33. Takashima A, Grinnell F: Fibronectin-mediated keratinocyte migration and initiation of fibronectin receptor function in vitro. J Invest Dermatol 1985;85:304–308.
34. Takashima A, Billingham RE, Grinnell F: Activation of rabbit keratinocyte fibronectin receptor function in vivo during wound healing. J Invest Dermatol 1986;86:585–590.
35. Doran JE, Raynor RH: Fibronectin binding to protein A-containing staphylococci. Infect Immun 1981;33:683–689.
36. Verbrugh HA, Peterson PK, Smith DF, et al: Human fibronectin binding to staphylococcal surface protein and its relative inefficiency in promoting phagocytosis by human polymorphonuclear leukocytes, monocytes and alveolar macrophages. Infect Immun 1981;33:811–819.
37. Hof DG, Repine JE, Peterson PK, et al: Phagocytosis by human alveolar macrophages and neutrophils: Qualitative differences in the opsonic requirements for uptake of Staphylococcus aureus and Streptococcus pneumoniae in vitro. Am Rev Respir Dis 1980;121:65–71.
38. Niehaus GD, Schumacker PR, Saba TM: Reticuloendothelial clearance of blood-borne particulates. Ann Surg 1980;191:479–487.
39. Peterson KM, Baseman JB, Alderete JF: Treponema pallidum receptor binding protein interacts with fibronectin. J Exp Med 1983;157:1958–1970.
40. Julkunen I, Hautanen A, Keski-Oja J: Interaction of viral envelope glycoproteins with fibronectin. Infect Immun 1983; 40:876–881.
41. Van de Water L, Destree AT, Hynes RO: Fibronectin binds to some bacteria but does not promote their uptake by phagocytic cells. Science 1983;220:201–204.
42. Czop JK: Phagocytosis of particulate activators of the alternative complement pathway: Effects of fibronectin. Adv Immunol 1986;38:361–398.
43. Bevilacqua MP, Amrani D, Mosesson MW, et al: Receptors for cold-insoluble globulin (plasma fibronectin) on human monocytes. J Exp Med 1981;153:42–60.
44. Pommier CG, Inada S, Fried LF, et al: Plasma fibronectin enhances phagocytosis of opsonized particles by human peripheral blood monocytes. J Exp Med 1983;157:1844–1845.
45. Brown EJ: The role of extracellular matrix proteins in the control of phagocytosis. J Leuk Biol 1986;39:579–591.
46. Grinnell F, Feld MK: Initial adhesion of human fibroblasts in serum-free medium: Possible role of secreted fibronectin. Cell 1979;17:117–129.
47. Clark RAF, Folkvord JM, Wertz RL: Fibronectin, as well as other extracellular matrix proteins, mediates human keratinocyte adherence. J Invest Dermatol 1985;84:378–383.
48. O'Keefe EJ, Payne RE Jr, Russell N, et al: Spreading and enhanced motility of human keratinocytes on fibronectin. J Invest Dermatol 1985;85:125–130.
49. Macarak EJ, Howard PS: Adhesion of endothelial cells to extracellular matrix proteins. J Cell Physiol 1983;116:76–86.
50. Palotie A, Tryggvason K, Peltonen L, et al: Components of subendothelial aorta basement membrane: Immunohistochemical localization and role in cell attachment. Lab Invest 1983;49:362–370.
51. Clark RAF, Folkvord JM, Nielsen LD: Either exogenous or endogenous fibronectin can promote adherence of human endothelial cells. J Cell Sci 1986;82:263–280.
52. Horsburgh CR, Clark RAF, Kirkpatrick CH: Lymphokines and platelets promote human monocyte adherence to fibrinogen and fibronectin in vitro. J Leuk Biol 1987;41:14–24.
53. Mosher DF: Cross-linking of cold-insoluble globulin by fibrin-stabilizing factor. J Biol Chem 1975;250:6614–6621.
54. Mosher DF, Johnson RB: Specificity of fibronectin-fibrin cross-linking. Ann NY Acad Sci 1983;408:583–594.
55. Ciano PS, Colvin RB, Dvorak AM, et al: Macrophage migration in fibrin gel matrices. Lab Invest 1986;54:62–70.
56. Grinnell F, Feld M, Minter D: Fibroblast adhesion to fibrinogen and fibrin substrata: Requirement for cold-insoluble globulin (plasma fibronectin). Cell 1980;19:517–525.
57. Grinnell F, Billingham RE, Burgess L: Distribution of fibronectin during wound healing in vivo. J Invest Dermatol 1981; 76:181–189.
58. Repesh LA, Fitzgerald TJ, Furcht LT: Fibronectin involvement in granulation tissue and wound healing in rabbits. J Histochem Cytochem 1982;30:351–358.
59. Clark RAF, Lanigan JM, DellaPelle P, et al: Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol 1982;70:264–269.
60. Clark RAF, DellaPelle P, Manseau E, et al: Blood vessel fibronectin increases in conjunction with endothelial cell proliferation and capillary ingrowth during wound healing. J Invest Dermatol 1982;79:269–276.
61. Nishida T, Nakagawa S, Awata T, et al: Fibronectin promotes epithelial migration of cultured rabbit cornea in situ. J Cell Biol 1983;97:1653–1657.
62. Donaldson DJ, Mahan JT, Hasty DL, et al: Location of a fibronectin domain involved in newt epidermal cell migration. J Cell Biol 1985;101:73–78.
63. Nishida T, Ohashi Y, Awata T, et al: Fibronectin: A new therapy for corneal trophic ulcer. Arch Ophthalmol 1983;101:1046–1048.
64. Singer II, Kawka DW, Kazazis DM, et al: In vivo codistribution of fibronectin and actin fibers in granulation tissue: Immunofluorescence and electron microscope studies of the fibronexus at the myofibroblast surface. J Cell Biol 1984;98:2091–2106.
65. Singer II, Kawka DW, Kazazis DM: Localization of the fibronexus at the surface of granulation tissue myofibroblasts using double-label immunogold electron microscopy on ultrathin frozen sections. Eur J Cell Biol 1985;38:94–101.
66. Fleischmajer R, Timpl R, Tuderman L, et al: Ultrastructural identification of extension aminopeptides of type I and III collagens in human skin. Proc Natl Acad Sci USA 1981;78:7360–7364.
67. Hedman K, Kurkinen M, Alitalo K, et al: Isolation of the pericellular matrix of human fibroblast cultures. J Cell Biol 1979; 81:83–91.
68. Hedman K, Johansson S, Vartio T, et al: Structure of the pericellular matrix: Association of heparan and chondroitin sulfate with fibronectin-procollagen fibers. Cell 1982;28:663–671.
69. Hedman K, Vartio T, Johansson S, et al: Integrity of the pericellular fibronectin matrix of fibroblasts is independent of sulfated glycosaminoglycans. EMBO J 1984;3:581–584.
70. Carter WG: The role of intermolecular disulfide bonding in deposition of GP 140 in the extracellular matrix. J Cell Biol 1984;99:105–114.
71. McDonald JA, Kelley DG, Broekelmann TJ: Role of fibronectin in collagen deposition: Fab1 to the gelatin-binding domain of fibronectin inhibits both fibronectin and collagen organization in fibroblast extracellular matrix. J Cell Biol 1982;92:485–492.
72. Ross R, Raines EW, Bowen-Pope DF: The biology of platelet-derived growth factor. Cell 1986;46:155–169.
73. Avnur Z, Geiger B: The removal of extracellular fibronectin from areas of cell-substrate contact. Cell 1981;25:121–132.
74. Chen WT, Hasegawa E, Hasegawa T, et al: Development of cell surface linkage complexes in cultured fibroblasts. J Cell Biol 1985;100:1103–1114.
75. Damskey CH, Knudsen KA, Bradley D, et al: Distribution of the cell substratum attachment (CSAT) antigen on myogenic and fibroblastic cells in culture. J Cell Biol 1985;100:1528–1539.
76. Furcht LT, Wendelschafer C, Mosher DF, et al: An axial periodic fibrillar arrangement of antigenic determinants for fibronectin and procollagen on ascorbate treated human fibroblasts. J Supramol Struct 1980;13:15–33.
77. Irish PS, Hasty DL: Immunocytochemical localization of fibronectin in human fibroblast cultures using a cell surface replica technique. J Histochem Cytochem 1980;31:69–77.
78. Oh E, Pierschbacher M, Ruoslahti E: Deposition of plasma fibronectin in tissues. Proc Natl Acad Aci USA 1981;78:3218–3221.
79. Millis AJ, Hoyle M, Mann DM, et al: Incorporation of cellular and plasma (fibronectin) into smooth muscle cell extracellular matrix in vitro. Proc Natl Acad Sci USA 1985;82:2746–2750.
80. McDonald JA, Quade BJ, Broekelmann TJ, et al: Both the cell adhesive domain and an aminoterminal matrix assembly domain participate in fibronectin assembly into fibroblast pericellular matrix. J Biol Chem 1987;262:2957–2967.
81. McKeown-Longo PJ, Mosher DF: Interaction of the 70 000-mol-wt aminoterminal fragment of fibronectin with the matrixassembly receptor of fibroblasts. J Cell Biol 1985;100:364–374.
82. Bitterman PB, Rennard SI, Adelbert S, et al: Role of fibronectin as a growth factor for fibroblasts. J Cell Biol 1983; 97:1925–1932.
83. Fava RA, McClure DB: Fibronectin-associated transforming growth factor. J Cell Physiol 1987;131:184–189.
84. Roberts AB, Anzano MA, Wakefield LM: Type β-transforming growth factor: A bifunctional regulator of cellular growth. Proc Natl Acad Sci USA 1985;82:119–123.
85. Sporn MB, Roberts AB, Shull JH, et al: Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo. Science 1983;219:1329–1331.
86. Roberts AB, Sporn MB, Assoian RK, et al: Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986;83:4167–4171.
87. Lawrence WT, Norton JA, Sporn MB, et al: The reversal of an adriamycin-induced healing impairment with chemoattractants and growth factors. Ann Surg 196;203:142–147.
88. Clark RAF, Quinn JH, Winn HJ, et al: Fibronectin is produced by blood vessels in response to injury. J Exp Med 1982; 156:646–651.
89. Clark RAF, Winn HJ, Dvorak HF, et al: Fibronectin beneath reepithelializing epidermis in vivo: Sources and significance. J Invest Dermatol 1983;80(suppl):26S–30S.
90. Saba TM, Blumenstock FA, Bernard H: Cryoprecipitate reversal of opsonic alpha-2-surface binding glycoprotein deficiencies in septic surgical trauma patients. Science 1978:201:622–624.
91. Lundsgaard-Hansen P, Doran JE, Ruli E, et al: Purified fibronectin administration to patients with severe abdominal infections: A controlled study. Ann Surg 1985;202:745–759.